Table 1.
Baseline characteristics of participants.
| PLR (tertile) | Low | Middle | High | P-value |
|---|---|---|---|---|
| N | 50 | 52 | 52 | |
| Age (years, mean ±SD) | 44.56±18.95 | 41.04±20.02 | 39.02±19.05 | 0.346 |
| Height (cm, mean ±SD) | 162.34±8.09 | 163.29±9.25 | 162.92±7.89 | 0.849 |
| Weight (kg, mean ±SD) | 59.76±9.76 | 59.71±9.93 | 56.62±8.70 | 0.158 |
| Sex (n, %) | 0.315 | |||
| Male | 20 (40.00%) | 20 (38.46%) | 14 (26.92%) | |
| Female | 30 (60.00%) | 32 (61.54%) | 38 (73.08%) | |
| Smoking (n, %) | 0.003 | |||
| No | 31 (62.00%) | 31 (59.62%) | 44 (84.62%) | |
| Current smoker | 16 (32.00%) | 17 (32.69%) | 2 (3.85%) | |
| Ex-smoker | 3 (6.00%) | 4 (7.69%) | 6 (11.54%) | |
| Alcohol consumption (n, %) | 0.671 | |||
| No | 43 (86.00%) | 42 (80.77%) | 45 (86.54%) | |
| Yes | 7 (14.00%) | 10 (19.23%) | 7 (13.46%) | |
| HP infection (n, %) | 0.941 | |||
| Negative | 35 (70.00%) | 38 (73.08%) | 37 (71.15%) | |
| Positive | 15 (30.00%) | 14 (26.92%) | 15 (28.85%) | |
| Diabetes history (n, %) | 0.198 | |||
| No | 44 (88.00%) | 43 (82.69%) | 48 (94.12%) | |
| Yes | 6 (12.00%) | 9 (17.31%) | 3 (5.88%) | |
| Hyperuricemia (n, %) | 0.149 | |||
| No | 38 (76.00%) | 42 (80.77%) | 47 (90.38%) | |
| Yes | 12 (24.00%) | 10 (19.23%) | 5 (9.62%) | |
| Cardiovascular diseases (n, %) | 0.959 | |||
| No | 43 (86.00%) | 45 (86.54%) | 44 (84.62%) | |
| Yes | 7 (14.00%) | 7 (13.46%) | 8 (15.38%) | |
| Bleeding in skin (n, %) | 0.144 | |||
| No | 39 (78.00%) | 32 (61.54%) | 39 (75.00%) | |
| Yes | 11 (22.00%) | 20 (38.46%) | 13 (25.00%) | |
| Bleeding in mucosa (n, %) | 0.763 | |||
| No | 36 (72.00%) | 35 (67.31%) | 34 (65.38%) | |
| Yes | 14 (28.00%) | 17 (32.69%) | 18 (34.62%) | |
| Bleeding in organ (n, %) | 0.684 | |||
| No | 44 (88.00%) | 48 (92.31%) | 48 (92.31%) | |
| Yes | 6 (12.00%) | 4 (7.69%) | 4 (7.69%) | |
| High-dose dexamethasone (n, %) | 0.004 | |||
| No | 23 (46.00%) | 28 (53.85%) | 40 (76.92%) | |
| Yes | 27 (54.00%) | 24 (46.15%) | 12 (23.08%) | |
| Oral prednisone (n, %) | 0.004 | |||
| No | 27 (54.00%) | 24 (46.15%) | 12 (23.08%) | |
| Yes | 23 (46.00%) | 28 (53.85%) | 40 (76.92%) | |
| Outcome (n, %) | 0.093 | |||
| Response | 42 (84.00%) | 50 (96.15%) | 48 (92.31%) | |
| No response | 8 (16.00%) | 2 (3.85%) | 4 (7.69%) |
PLR – platelet to lymphocyte ratio; MPV – mean platelet volume; MPD – mean platelet distribution width; HP – Helicobacter pylori.